Overview

The Effect of Food (High Fat and Low Fat Breakfast) on the Pharmacokinetics of Regorafenib

Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
An open label, three way crossover study to determine the effect of a high fat breakfast or a low fat breakfast on the pharmacokinetics of a single dose of regorafenib.
Phase:
Phase 1
Details
Lead Sponsor:
Bayer